Back to search

Article

How to Read a Next-Generation Sequencing Report for AML and MDS—What Hematologists Need to Know

2025-11-03

Abstract excerpt

Acute myeloid leukemia (AML) and myelodysplastic neoplasms (MDS) are clonal hematopoietic malignancies in which next-generation sequencing (NGS) has become integral for diagnosis, classification, risk stratification, and measurable residual dis-ease (MRD) monitoring. Traditional cytogenetic and PCR-based assays remain useful, but targeted NGS panels now represent the standard of care, providing rapid and sen-sitiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32c4c8c6-b7a2-5487-99d8-b47e13693078
DOI
10.20944/preprints202511.0013.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
How to Read a Next-Generation Sequencing Report for AML and MDS—What Hematologists Need to KnowDOI 10.20944/preprints202511.0013.v1
Select a neighboring publication to make it the new centre.